PATENT CLAIM ANALYSIS

Application Number: 16018683
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "235200"]

Abstract:
This application discloses compounds according to generic Formula (I): wherein all variables are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are useful for the treatment of oncological, auto-immune, and inflammatory diseases caused by aberrant B-cell activation. Also disclosed are compositions containing compounds of Formula (I) and at least one carrier, diluent or excipient.

Claim (Index 6):
The compound of any one of  claims 1 - 4 , wherein R 1  is H and R 2  is cyano.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.51724
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15102315', '15102832', '15102043', '12378978', '14520279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7998298973424461
- 35 USC 102 Novelty (BERT): 0.5785806242122722
- Combined Prediction Score: 0.7777049700294288
- Mean Citation Score: 416.57007600000014
- Max Citation Score: 482.6693
- Similarity Product: 378.7203517722488

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test